Productname : Acenomac 3
GenericName : Nicoumalone Tablets
Manufacturer : Macleods Pharmaceuticals Ltd
Acenomac 3Mg Tablet is a medicament toprevent blood clots which might be harmful and even fatal, thereby reducing thechances of stroke and cardiac arrest. It helps in increasing andcatalyzing blood flow in the body by reducing the amount of blood clottingproteins in the blood stream. In simple term it is an anti-coagulant also knownas blood thinner and belongs to semi synthetic origin. It is prescribed inconditions like deep vein thrombosis, myocardial infarction, pulmonary embolism, rheumatic heart diseases. It is usually orallyadministered. The dosage depends on the condition of the patient, viscosity ofblood etc.
This drug called Acenomac 3Mg Tablet has some side effectswhen wrongly or abnormally administered the most irreversible of which is Skinnecrosis, but this is not very common. Temporary hair loss may be seen as well in few cases. Nausea,head ache, drowsiness, stomach problems, diarrhea are more common. If Acenomac3Mg Tablet is overdosed or it works too strongly then bleeding mayhappen. Doctor should be consulted as soon as possible in such case to top thebleeding. Nosebleed, blood in stool, dark urine, unusual pain, swellingordiscomfort are symptoms which needs urgent medical attention.
Uses of Acenomac Tablet
Acenomac 3 mg Tablet is used for prevention of blood clots. Itis used to prevent and treat blood clots forming in the legs, lungs, brain orheart.
AcenomacTablet side effects
Side Effect ofAcenomac is Bleeding.
How to useAcenomac Tablet
Take this medicine in the dose and duration as advised by yourdoctor. Swallow it as a whole. Do not chew, crush or break it. Acenomac 3 mgTablet may be taken with or without food, but it is better to take it at afixed time.
HowAcenomac Tablet works
Acenomac 3 mg Tablet is an oral anticoagulant. It acts bypreventing the formation of harmful blood clots. Although it does not dissolvethe existing blood clots, it inhibits them from growing larger and causingserious problems.